52 patients suffering from migraine were evenly assigned to two groups of A (receivers of sodium valproate) and B (receivers of levetiracetam). Patients of both groups visited the hospital in three mo Levetiracetam sodium valproate migraine headaches
Conditions
Interventions
52 patients suffering from migraine were evenly assigned to two groups of A (receivers of sodium valproate) and B (receivers of levetiracetam). Patients of both groups visited the hospital in three mo
as well as the frequency of aura attacks and examining the side-
effects
Experimental Drug
drug
Sponsors
Azad Islamic University
Azad Islamic University
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria included: diagnosis of migraine based on the criteria of International Headache Society, 6 months of migraine attacks with auras, and no history of diseases that are compounded with headaches, consumption of prophylaxis for migraine in last 6 months.
Exclusion criteria
Exclusion criteria: drugs leading to headaches including Nitrogen compounds, oral contraceptive pills and alcohol. Patients who were not interested in the study, or the prescribed medicine was not effective in them, were discarded from the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| migraine 3 months after the end of intervention visual Analog Scale | — |
Secondary
| Measure | Time frame |
|---|---|
| headache reduction 3 months after the end of intervention visual Analog Scale | — |
Contacts
Public Contactzahra fotoukian
babaol medical sciences university
Outcome results
None listed